Yatin Suneja Analyst PerformanceBiotechnology Research Analyst - Specializes in I&I, CNS at GuggenheimYatin Suneja is a stock analyst at Guggenheim focused in the medical sector, covering 35 publicly traded companies. Over the past year, Yatin Suneja has issued 33 stock ratings, including buy and hold recommendations. While full access to Yatin Suneja's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yatin Suneja's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings88 Last 9 YearsBuy Recommendations75.00% 66 Buy RatingsCompanies Covered35 Unique Companies Ratings Distribution88RatingsDistribution of strong buy, buy, hold, and sell ratings by Yatin Suneja.RatingPercentageCount Strong Buy0.0%0 ratings Buy75.0%66 ratings Hold25.0%22 ratings Sell0.0%0 ratingsOut of 88 total stock ratings issued by Yatin Suneja at Guggenheim, the majority (75.0%) have been Buy recommendations, followed by 25.0% Hold.Best & Worst CallsBest Call0000.0%GLYCNov 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AXSMApr 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ97.1% of companies on NASDAQ34 companiesNYSE2.9% of companies on NYSE1 companyYatin Suneja, an analyst at Guggenheim, currently covers 35 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical34 companies97.1%Miscellaneous1 company2.9%Yatin Suneja of Guggenheim specializes in stock coverage within the Medical sector, with additional focus on companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE22 companies62.9%PHARMACEUTICAL PREPARATIONS7 companies20.0%MED - DRUGS3 companies8.6%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC1 company2.9%BIOTECHNOLOGY1 company2.9%Miscellaneous1 company2.9% About Yatin SunejaMr. Suneja is a Senior Managing Director and Equity Research Analyst covering the Biotechnology sector, with over 16 years of experience in equity research. Since joining Guggenheim in 2018, he has provided in-depth analysis and investment insights on biotechnology companies, with a particular focus on those in the immunology, neurology, and inflammatory (INI) space. Previously, he was a Managing Director at SunTrust Robinson Humphrey and a Vice President at Cowen & Company, both specializing in biotechnology equity research. He began his career in Corporate Banking at Bank of America. Mr. Suneja holds an M.B.A. from Syracuse University and a B.Com from PGDAV College, University of Delhi.Follow on LinkedIn Yatin Suneja's Ratings History at Guggenheim Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTRMLTourmaline Bio9/10/2025Reiterated Rating$47.64$48.00Neutral$0.0000.00% ROITRMLTourmaline Bio9/9/2025Downgrade$47.64Hold$0.0000.00% ROIDNTHDianthus Therapeutics9/9/2025Boost Price Target$31.80$100.00Buy$0.0000.00% ROIFBRXForte Biosciences8/18/2025Initiated Coverage$11.57$75.00Buy$0.0000.00% ROIFBRXForte Biosciences8/18/2025Initiated Coverage$11.49$75.00Buy$0.0000.00% ROITRMLTourmaline Bio8/14/2025Reiterated Rating$21.88$55.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals8/1/2025Boost Price Target$545.46$815.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences8/1/2025Boost Price Target$126.03$175.00Buy$0.0000.00% ROIARGXargenex8/1/2025Boost Price Target$667.75$1,070.00Buy$0.0000.00% ROIABVXAbivax7/23/2025Boost Price Target$10.00$101.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. LRMRLarimar Therapeutics6/24/2025Reiterated Rating$2.42$26.00Buy$0.0000.00% ROIALMSAlumis6/10/2025Upgrade$3.43$18.00Buy$0.0000.00% ROIANABAnaptysBio5/28/2025Reiterated Rating$21.95$90.00Buy$0.0000.00% ROIVIGLVigil Neuroscience5/22/2025Set Price Target$7.88$8.00Neutral$0.0000.00% ROICABACabaletta Bio5/15/2025Boost Price Target$1.70$25.00Buy$0.0000.00% ROIARGXargenex5/9/2025Lower Price Target$547.89$1,065.00Buy$0.0000.00% ROIANABAnaptysBio5/6/2025Boost Price Target$20.97$54.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences5/6/2025Boost Price Target$125.03$165.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals5/2/2025Lower Price Target$2.76$12.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals5/1/2025Lower Price Target$589.21$810.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals4/2/2025Reiterated Rating$5.98Buy$0.0000.00% ROICABACabaletta Bio4/1/2025Reiterated Rating$1.32$23.00Buy$0.0000.00% ROIIFRXInflaRx3/26/2025Boost Price Target$1.33$10.00Buy$0.0000.00% ROIZURAZura Bio3/26/2025Reiterated Rating$1.37$15.00Buy$0.0000.00% ROILRMRLarimar Therapeutics3/25/2025Reiterated Rating$2.29$26.00Buy$0.0000.00% ROIIMVTImmunovant3/20/2025Reiterated Rating$18.84Buy$0.0000.00% ROIDNTHDianthus Therapeutics3/12/2025Reiterated Rating$23.06$84.00Buy$0.0000.00% ROIARGXargenex3/10/2025Boost Price Target$575.37$1,100.00Buy$0.0000.00% ROIIMVTImmunovant3/10/2025Reiterated Rating$20.28Buy$0.0000.00% ROINMRANeumora Therapeutics3/7/2025Downgrade$1.52Neutral$0.0000.00% ROINBIXNeurocrine Biosciences2/10/2025Lower Price Target$122.62$163.00Buy$0.0000.00% ROIIMVTImmunovant2/10/2025Lower Price Target$20.41$44.00Buy$0.0000.00% ROIVIGLVigil Neuroscience1/24/2025Reiterated Rating$2.49Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
